AA
AlphaCentric Advisors’s Aurinia Pharmaceuticals AUPH Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-80,000
| Closed | -$457K | – | 231 |
|
2024
Q2 | $457K | Hold |
80,000
| – | – | 0.34% | 84 |
|
2024
Q1 | $401K | Buy |
80,000
+30,000
| +60% | +$150K | 0.24% | 91 |
|
2023
Q4 | $450K | Hold |
50,000
| – | – | 0.3% | 77 |
|
2023
Q3 | $389K | Hold |
50,000
| – | – | 0.22% | 107 |
|
2023
Q2 | $484K | Sell |
50,000
-27,500
| -35% | -$266K | 0.27% | 98 |
|
2023
Q1 | $849K | Sell |
77,500
-275,000
| -78% | -$3.01M | 0.59% | 63 |
|
2022
Q4 | $1.52M | Buy |
352,500
+193,000
| +121% | +$834K | 1.5% | 12 |
|
2022
Q3 | $1.2M | Buy |
+159,500
| New | +$1.2M | 1.23% | 17 |
|
2021
Q3 | – | Sell |
-25,000
| Closed | -$324K | – | 198 |
|
2021
Q2 | $324K | Sell |
25,000
-10,000
| -29% | -$130K | 0.09% | 84 |
|
2021
Q1 | $454K | Buy |
35,000
+15,000
| +75% | +$195K | 0.15% | 49 |
|
2020
Q4 | $277K | Buy |
20,000
+15,900
| +388% | +$220K | 0.12% | 45 |
|
2020
Q3 | $60K | Buy |
+4,100
| New | +$60K | 0.03% | 94 |
|